ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Tivantinib Hampers the Proliferation of Glioblastoma Cells via PI3K/Akt/Mammalian Target of Rapamycin (mTOR) Signaling.

Yukun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.